Delivery Order SPE2DR25D3018-SPE2DR26FR8RN
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Adderall XR 30 mg capsules (100-count units) with a ceiling value of $1,156.08. This is a firm fixed-price delivery order with no set-aside designation, executed as a competitive award. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a $12,429.65 firm fixed price delivery order to AmerisourceBergen Drug Corp for Adderall XR 10 mg capsules (100-count units) on September 10, 2025, with an ultimate completion date of September 11, 2025. This non-set-aside contract was awarded competitively and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $1,281.99 delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Adderall XR 30 mg capsules (100-count containers). This firm fixed-price contract is non-set-aside and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The place of performance is AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $1.73K to AmerisourceBergen Drug Corp for Adderall XR 10 mg capsules (100-count units) on November 18, 2025, with an ultimate completion date of November 19, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and specifies Conshohocken, Pennsylvania as the place of performance, which aligns with the vendor's corporate headquarters location. The delivery order is a child contract under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Adderall XR 30 mg capsules (100-count units) with a ceiling value of $5,587.61. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of October 21, 2025. The delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Adderall XR 5 mg capsules (100-count units) with a ceiling value of $3,463.01. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The contract utilizes AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999, which runs through December 2026...
- The Defense Logistics Agency awarded a delivery order valued at $3,890.69 to AmerisourceBergen Drug Corp for the supply of Adderall XR 10 mg capsules (100-count units) on September 16, 2025, with an ultimate completion date of September 17, 2025. This contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was awarded through competitive procurement. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a $3,683.22 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Adderall XR 20 mg capsules (100-count units) on May 27, 2025, with an ultimate completion date of May 28, 2025. This non-set-aside contract was competitively awarded and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Adderall XR 10 mg capsules (100-count units) with a contract ceiling value of $2,089.62. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order is scheduled for ultimate completion by November 6, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $7,522.83 to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Adderall XR 25 mg capsules (100-count units). This firm fixed-price contract, with an ultimate completion date of October 23, 2025, was competitively awarded without a set-aside designation. The pharmaceutical will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under...
- SPE2DR25D3018Indefinite Delivery Contract
- SPE2DR25D3018-SPE2DR26FR8RNDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,686.64 to AmerisourceBergen Drug Corp for the supply of Adderall XR 25 mg capsules (100 count) on November 20, 2025, with an ultimate completion date of November 21, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor providing a broad range of medications and medical supplies to support military and veteran healthcare systems. As a for-profit organization registered in the System for Award Management, the company maintains an extensive portfolio of federal contract awards with the Defense Logistics Agency covering multiple therapeutic domains, including neurological treatments, pain management pharmaceuticals, diabetes medications, antibiotics, and specialized medical supplies. The company's demonstrated capability to fulfill federal medical procurement requirements through open competition, combined with its substantial IDC with DLA, positions it as a strategic supplier supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 11/20/25 |